‘We know how difficult this situation has been.’

The shortage of abatacept (Orencia) subcutaneous presentations has now been resolved... but pharmacists are being advised to help prevent stockpiling Bristol-Myers Squibb Australia has announced that the shortage is over, the Therapeutic Goods Administration advised on Monday. “We understand how difficult this situation has been for many Australians,” the TGA says. “We acknowledge and thank